Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Urologia Internationalis|January 15, 2024
Cyclin A2 Expression as Predictive Biomarker in Muscle-Invasive Upper Tract Urothelial CarcinomaMargarete Teresa Walach, Katja Nitschke, Matthias Groß-Weege, et al.
Molecular Cancer|March 8, 2025
Small extracellular vesicles and particles (sEVPs) derived from tumor-free pre-metastatic organs promote breast cancer metastasis and support organotropismTasneem Cheytan, Martin Schneider, Roberto Würth, et al.
Oncotarget|March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomyMarkus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.
Discover Oncology|December 15, 2022
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapyManuel Neuberger, Christel Weiß, Nora Goly, et al.
Journal of Cancer Research and Clinical Oncology|August 8, 2022
Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohortManuel Neuberger, Nora Goly, Janina Skladny, et al.
Journal of Hepatology|August 28, 2013
HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitopeKatja Nitschke, Alejandro Barriga, Julia Schmidt, et al.
Cancers|December 28, 2019
miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection MarkersThomas Stefan Worst, Christopher Previti, Katja Nitschke, et al.
Anticancer Research|March 29, 2022
Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel ChemotherapyManuel Neuberger, Janina Skladny, Nora Goly, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutationsChristoph Neumann-Haefelin, Cesar Oniangue-Ndza, Thomas Kuntzen, et al.
Pageof 4